An Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon Cancer

NCT01442155 · clinicaltrials.gov ↗

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Capecitabine
BIOLOGICAL: Oxaliplatin

Sponsor

Hoffmann-La Roche